Skip to main content
Premium Trial:

Request an Annual Quote

Luminex Q2 Revenues Rise, Losses Narrow

NEW YORK, July 23 - Luminex today reported increased net revenues for the second quarter, and significantly narrowed net losses.


The Austin, Texas company, which makes the xMap bead assay system for genomics and proteomics research, and other applications, reported revenues of $5.6 million for the quarter, compared to $3.2 million for the second quarter of 2002.


The company's R&D expenses were down sharply to $.9 million, from $2.1 million for the year-ago period.

Net losses for the quarter came to $1.9 million, compared to $6.2 million for the same period last year.


As of June 30, Luminex had $38.7 million in cash and cash equivalents.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.